| 产品名称： | Pseudomonas aeruginosa (Schroeter) Migula |
|---|---|
| 商品货号： | TS170504 |
| Strain Designations： | 2192 |
| Application： | Used to produce a mucoid exo-polysaccharide vaccine Opportunistic pathogen research Respiratory research |
| Isolation： | Sputum from a cystic fibrosis patient, Boston, MA |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | Harvard Medical School |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC |
| References： | Pier GB. Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa. US Patent 4,578,458 dated Mar 25 1986 Pier GB, et al. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J. Infect. Dis. 147: 494-503, 1983. PubMed: 6220094 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Pseudomonas aeruginosa (Schroeter) Migula |
|---|---|
| 商品货号： | TS170504 |
| Strain Designations： | 2192 |
| Application： | Used to produce a mucoid exo-polysaccharide vaccine Opportunistic pathogen research Respiratory research |
| Isolation： | Sputum from a cystic fibrosis patient, Boston, MA |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 18: Trypticase Soy Agar/Broth |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | Harvard Medical School |
| U.S. Patent Number： | |
| Chain of Custody： | ATCC |
| References： | Pier GB. Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa. US Patent 4,578,458 dated Mar 25 1986 Pier GB, et al. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa. J. Infect. Dis. 147: 494-503, 1983. PubMed: 6220094 |
